See my options Entities covered Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
Frequently asked questions Semaglutide is a GLP-1 receptor agonist that curbs appetite and slows how fast your stomach empties, working on an appetite hormone your body already makes
Patients should discuss with their health care provider if they have symptoms of pancreatitis or gallstones
These statistics show that semaglutide demonstrated a greater A1C control in diabetics compared to dulaglutide in indirect and pooled analysis
Key Benefits: Semaglutide: Reduces appetite, delays gastric emptying, and improves blood sugar control Glycine: Supports metabolic function and may improve insulin sensitivity Vitamin B12: Boosts energy, supports red blood cell production, and prevents deficiency during calorie restriction Ideal For: Medically assisted weight loss programs Individuals with insulin resistance or type 2 diabetes Patients seeking an energy-boosting and fat-burning aid Usage: Administer as directed by your healthcare provider, typically once weekly via subcutaneous injection
